ESR1 and breast carcinoma: Another probable pathway is 27HC, which is a cholesterol metabolite that promotes estrogen receptor (ER)-positive breast cancer in vitro, and an ER agonist that could inhibit the liver X receptor-a regulator of cholesterol [49].